CM
GILD icon

Capital Management’s Gilead Sciences GILD Stock Holding History

Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-56,614
Closed -$3.96M – 85
2021
Q3 		$3.96M Sell
56,614
-77,984
-58% -$5.48M 0.86% 43
2021
Q2 		$9.27M Sell
134,598
-53,730
-29% -$3.59M 1.97% 22
2021
Q1 		$12.2M Buy
188,328
+36,680
+24% +$2.37M 2.72% 14
2020
Q4 		$8.84M Buy
151,648
+8
+0% +$483 2.41% 20
2020
Q3 		$9.58M Buy
151,640
+31,325
+26% +$2.17M 3.01% 13
2020
Q2 		$9.26M Sell
120,315
-48,555
-29% -$3.72M 3.09% 13
2020
Q1 		$12.6M Buy
168,870
+35,220
+26% +$2.43M 4.62% 3
2019
Q4 		$8.69M Sell
133,650
-3,881
-3% -$253K 2.21% 20
2019
Q3 		$8.72M Buy
137,531
+306
+0.2% +$20K 2.39% 15
2019
Q2 		$9.27M Buy
137,225
+10,514
+8% +$692K 2.56% 16
2019
Q1 		$8.24M Buy
126,711
+38,983
+44% +$2.59M 2.26% 20
2018
Q4 		$5.49M Sell
87,728
-43,554
-33% -$3.04M 1.7% 30
2018
Q3 		$10.1M Buy
131,282
+2,105
+2% +$159K 2.59% 15
2018
Q2 		$9.15M Buy
129,177
+13,228
+11% +$934K 2.46% 15
2018
Q1 		$8.74M Sell
115,949
-923
-0.8% -$73.4K 2.35% 19
2017
Q4 		$8.37M Sell
116,872
-9,986
-8% -$758K 2.27% 21
2017
Q3 		$10.3M Buy
126,858
+30
+0% +$2.29K 2.94% 10
2017
Q2 		$8.98M Sell
126,828
-952
-0.7% -$63.4K 2.68% 10
2017
Q1 		$8.68M Buy
127,780
+48,904
+62% +$3.44M 2.69% 11
2016
Q4 		$5.65M Sell
78,876
-18,350
-19% -$1.36M 1.89% 26
2016
Q3 		$7.69M Sell
97,226
-8,005
-8% -$650K 2.84% 11
2016
Q2 		$8.78M Sell
105,231
-9,544
-8% -$847K 3.4% 5
2016
Q1 		$10.5M Buy
114,775
+16,125
+16% +$1.45M 4.08% 2
2015
Q4 		$9.98M Buy
98,650
+13,389
+16% +$1.39M 3.79% 2
2015
Q3 		$8.37M Buy
85,261
+34,907
+69% +$3.88M 3.36% 5
2015
Q2 		$5.89M Buy
+50,354
New +$5.5M 2.05% 26

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Management's GILD Position: Q4 2021 in Review

Capital Management sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 56,614 shares — an estimated $3.96M sold.

Capital Management first reported a position in GILD in Q2 2015 and held it in 26 quarters. The position peaked at $12.6M in Q1 2020. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Capital Management reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Capital Management sold 56,614 Gilead Sciences shares in Q4 2021, an estimated $3.96M.
  • Capital Management first reported a position in Gilead Sciences in Q2 2015 and held it in 26 quarters.
  • Capital Management's Gilead Sciences position peaked at $12.6M in Q1 2020.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Capital Management's 13F filing for Q4 2021, filed 8 Feb 2022.